These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38665691)

  • 1. Dose response relationship between D-dimer level and mortality in critically ill COVID-19 patients: a retrospective observational study.
    Aditianingsih D; Soenarto RF; Puiantana AM; Pranata R; Lim MA; Raharja PAR; Birowo P; Meyer M
    F1000Res; 2022; 11():269. PubMed ID: 38665691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019.
    Short SAP; Gupta S; Brenner SK; Hayek SS; Srivastava A; Shaefi S; Singh H; Wu B; Bagchi A; Al-Samkari H; Dy R; Wilkinson K; Zakai NA; Leaf DE;
    Crit Care Med; 2021 May; 49(5):e500-e511. PubMed ID: 33591017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
    Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of D-dimer in patients with COVID-19: prognosis value.
    Oualim S; Abdeladim S; Ouarradi AE; Bensahi I; Hafid S; Naitlho A; Bouaiti E; Sabry M
    Pan Afr Med J; 2020; 35(Suppl 2):105. PubMed ID: 33282060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-dimer, CRP, PCT, and IL-6 Levels at Admission to ICU Can Predict In-Hospital Mortality in Patients with COVID-19 Pneumonia.
    Milenkovic M; Hadzibegovic A; Kovac M; Jovanovic B; Stanisavljevic J; Djikic M; Sijan D; Ladjevic N; Palibrk I; Djukanovic M; Velickovic J; Ratkovic S; Brajkovic M; Popadic V; Klasnja S; Toskovic B; Zdravkovic D; Crnokrak B; Markovic O; Bjekic-Macut J; Aleksic A; Petricevic S; Memon L; Milojevic A; Zdravkovic M
    Oxid Med Cell Longev; 2022; 2022():8997709. PubMed ID: 35237386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study.
    Montrucchio G; Sales G; Rumbolo F; Palmesino F; Fanelli V; Urbino R; Filippini C; Mengozzi G; Brazzi L
    PLoS One; 2021; 16(2):e0246771. PubMed ID: 33556140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
    Xu Y; Qian Y; Gu Q; Tang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of initial coagulation and fibrinolytic markers on mortality in patients with severe blunt trauma: a multicentre retrospective observational study.
    Ishii K; Kinoshita T; Kiridume K; Watanabe A; Yamakawa K; Nakao S; Fujimi S; Matsuoka T
    Scand J Trauma Resusc Emerg Med; 2019 Feb; 27(1):25. PubMed ID: 30819212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-dimer Level and Diabetes in the COVID-19 Infection.
    Miri C; Charii H; Bouazzaoui MA; Laouan Brem F; Boulouiz S; Abda N; Kouismi H; Bazid Z; Ismaili N; El Ouafi N
    Clin Appl Thromb Hemost; 2021; 27():10760296211045902. PubMed ID: 34590493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study.
    Chocron R; Duceau B; Gendron N; Ezzouhairi N; Khider L; Trimaille A; Goudot G; Weizman O; Alsac JM; Pommier T; Bory O; Cellier J; Philippe A; Geneste L; Ben Abdallah I; Panagides V; El Batti S; Marsou W; Juvin P; Deney A; Messas E; Attou S; Planquette B; Mika D; Gaussem P; Fauvel C; Diehl JL; Pezel T; Mirault T; Sutter W; Sanchez O; Bonnet G; Cohen A; Smadja DM;
    Arch Cardiovasc Dis; 2021 May; 114(5):381-393. PubMed ID: 33846096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercoagulable viscoelastic blood clot characteristics in critically ill coronavirus disease 2019 patients and associations with thrombotic complications.
    Roh DJ; Eiseman K; Kirsch H; Yoh N; Boehme A; Agarwal S; Park S; Connolly ES; Claassen J; Wagener G
    J Trauma Acute Care Surg; 2021 Jan; 90(1):e7-e12. PubMed ID: 33009340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19.
    Poudel A; Poudel Y; Adhikari A; Aryal BB; Dangol D; Bajracharya T; Maharjan A; Gautam R
    PLoS One; 2021; 16(8):e0256744. PubMed ID: 34437642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19).
    Al-Samkari H; Song F; Van Cott EM; Kuter DJ; Rosovsky R
    Am J Hematol; 2020 Dec; 95(12):1479-1485. PubMed ID: 32780525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy.
    Popadic V; Klasnja S; Milic N; Rajovic N; Aleksic A; Milenkovic M; Crnokrak B; Balint B; Todorovic-Balint M; Mrda D; Zdravkovic D; Toskovic B; Brankovic M; Markovic O; Bjekic-Macut J; Djuran P; Memon L; Brajkovic M; Todorovic Z; Hadzi-Djokic J; Jovanovic I; Nikolic D; Zdravkovic M
    Oxid Med Cell Longev; 2021; 2021():6648199. PubMed ID: 33968298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic and liver function parameters as COVID-19 severity markers.
    Iqbal Q; Mudatsir M; Harapan H; Nurjannah N; Maulana T
    Narra J; 2024 Apr; 4(1):e178. PubMed ID: 38798852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, outcomes, and utilization of intensive care unit resources for critically ill COVID-19 patients in Libya: A prospective multi-center cohort study.
    Elhadi M; Alsoufi A; Abusalama A; Alkaseek A; Abdeewi S; Yahya M; Mohammed A; Abdelkabir M; Huwaysh M; Amkhatirah E; Alshorbaji K; Khel S; Gamra M; Alhadi A; Abubaker T; Anaiba M; Elmugassabi M; Binnawara M; Khaled A; Zaid A; Msherghi A
    PLoS One; 2021; 16(4):e0251085. PubMed ID: 33930079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent lymphocyte reduction and interleukin-6 levels are independently associated with death in patients with COVID-19.
    Xu Y; Wang N; Shen X; Liu X; Liu H; Liu Y
    Clin Exp Med; 2023 Nov; 23(7):3719-3728. PubMed ID: 37310657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome.
    Yousaf MN; Sarwar S; Tarique S; Ahmed M; Tahir H
    J Coll Physicians Surg Pak; 2022 Jan; 32(1):37-41. PubMed ID: 34983145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of D-dimer with severity and mortality in SARS-CoV-2 patients : A meta-analysis.
    Nugroho J; Wardhana A; Maghfirah I; Mulia EPB; Rachmi DA; A'yun MQ; Septianda I
    Int J Lab Hematol; 2021 Feb; 43(1):110-115. PubMed ID: 32931146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a prediction model for mortality in critically ill COVID-19 patients.
    Sun X; Tang J; Lu J; Zhang H; Li C
    Front Cell Infect Microbiol; 2024; 14():1309529. PubMed ID: 38979512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.